Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland

201724 citationsJournal Articlegreen Open Access

Authors

Oddur Ingimarsson · University of Iceland

James H. MacCabe · King's College London

Magnús Haraldsson · University of Iceland

Halldóra Jónsdóttir · University of Iceland

Engilbert Sigurðsson · National University Hospital of Iceland

Abstract

Clinicians must take active steps to reduce the risk of T2D and raised triglycerides in patients with schizophrenia. Antipsychotics were associated with a greater risk of T2D developing in females compared to males.

Topics & Keywords

Schizophrenia research and treatment Diet and metabolism studies Diabetes, Cardiovascular Risks, and Lipoproteins

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Nordic Journal of Psychiatry

Volume 71, Issue 7, pp. 496-502

DOI: 10.1080/08039488.2017.1334821

Field-Weighted Citation Impact: 2.00